Clínica Baviera, S.A. (CBAV.MC)
EUR 31.4
(-1.26%)
EUR 31.4
(-1.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 47.27 Million EUR | 18.24% |
| 2022 | 39.97 Million EUR | -22.45% |
| 2021 | 51.55 Million EUR | -5.99% |
| 2020 | 54.83 Million EUR | 2.28% |
| 2019 | 53.61 Million EUR | 298.53% |
| 2018 | 13.45 Million EUR | -10.1% |
| 2017 | 14.96 Million EUR | -10.41% |
| 2016 | 16.7 Million EUR | 17.71% |
| 2015 | 14.19 Million EUR | -11.87% |
| 2014 | 16.1 Million EUR | 38.38% |
| 2013 | 11.63 Million EUR | -27.84% |
| 2012 | 16.12 Million EUR | -15.68% |
| 2011 | 19.12 Million EUR | 4.23% |
| 2010 | 18.34 Million EUR | -16.94% |
| 2009 | 22.09 Million EUR | -2.06% |
| 2008 | 22.55 Million EUR | 206.72% |
| 2007 | 7.35 Million EUR | -18.47% |
| 2006 | 9.01 Million EUR | 0.41% |
| 2005 | 8.98 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 46.49 Million EUR | -1.94% |
| 2024 Q2 | 1.51 Million EUR | -96.74% |
| 2023 Q4 | 47.41 Million EUR | 1.84% |
| 2023 Q2 | 3.52 Million EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q3 | 46.55 Million EUR | 1221.54% |
| 2023 FY | 47.27 Million EUR | 18.24% |
| 2022 Q2 | 8.38 Million EUR | -82.35% |
| 2022 Q1 | 47.54 Million EUR | -7.78% |
| 2022 FY | 39.97 Million EUR | -22.45% |
| 2022 Q4 | 39.97 Million EUR | -7.89% |
| 2022 Q3 | 43.4 Million EUR | 417.4% |
| 2021 Q1 | 54.94 Million EUR | 0.19% |
| 2021 Q3 | 49.46 Million EUR | 267.45% |
| 2021 Q4 | 51.55 Million EUR | 4.23% |
| 2021 Q2 | 13.46 Million EUR | -75.5% |
| 2021 FY | 51.55 Million EUR | -5.99% |
| 2020 Q1 | 61.34 Million EUR | 14.41% |
| 2020 Q2 | 19.41 Million EUR | -68.35% |
| 2020 Q3 | 56.49 Million EUR | 190.97% |
| 2020 Q4 | 54.83 Million EUR | -2.93% |
| 2020 FY | 54.83 Million EUR | 2.28% |
| 2019 Q2 | 18.5 Million EUR | -61.55% |
| 2019 FY | 53.61 Million EUR | 298.53% |
| 2019 Q3 | 55.05 Million EUR | 197.55% |
| 2019 Q4 | 53.61 Million EUR | -2.61% |
| 2019 Q1 | 48.11 Million EUR | 257.65% |
| 2018 Q2 | 16.07 Million EUR | 0.0% |
| 2018 Q4 | 13.45 Million EUR | -15.36% |
| 2018 FY | 13.45 Million EUR | -10.1% |
| 2018 Q3 | 15.89 Million EUR | -1.1% |
| 2017 Q4 | 14.96 Million EUR | 0.0% |
| 2017 FY | 14.96 Million EUR | -10.41% |
| 2017 Q2 | 18.15 Million EUR | 10.84% |
| 2017 Q1 | 16.37 Million EUR | -1.96% |
| 2016 Q4 | 16.7 Million EUR | 0.0% |
| 2016 Q2 | 13.77 Million EUR | 0.0% |
| 2016 FY | 16.7 Million EUR | 17.71% |
| 2015 FY | 14.19 Million EUR | -11.87% |
| 2015 Q2 | 16.26 Million EUR | 0.0% |
| 2015 Q4 | 14.19 Million EUR | 0.0% |
| 2014 Q2 | 14.46 Million EUR | 0.0% |
| 2014 FY | 16.1 Million EUR | 38.38% |
| 2014 Q4 | 16.1 Million EUR | 0.0% |
| 2013 Q4 | 11.63 Million EUR | 0.0% |
| 2013 Q2 | 14.28 Million EUR | 0.0% |
| 2013 FY | 11.63 Million EUR | -27.84% |
| 2012 FY | 16.12 Million EUR | -15.68% |
| 2012 Q2 | 18.74 Million EUR | 0.0% |
| 2012 Q4 | 16.12 Million EUR | 0.0% |
| 2011 FY | 19.12 Million EUR | 4.23% |
| 2011 Q2 | 18.79 Million EUR | 0.0% |
| 2011 Q4 | 19.12 Million EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 FY | 18.34 Million EUR | -16.94% |
| 2010 Q4 | 18.34 Million EUR | 0.0% |
| 2009 FY | 22.09 Million EUR | -2.06% |
| 2009 Q4 | 22.09 Million EUR | 0.0% |
| 2008 FY | 22.55 Million EUR | 206.72% |
| 2007 FY | 7.35 Million EUR | -18.47% |
| 2006 FY | 9.01 Million EUR | 0.41% |
| 2005 FY | 8.98 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pangaea Oncology, S.A. | 5.72 Million EUR | -724.989% |